|
mass 451.475 g/molPharmacokinetic dataBioavailability 65%Protein description of doxazosin 4mg 98%Metabolism HepaticHalf life 22 hoursExcretion ?Therapeutic considerationsPregnancy cat. ?Legal status ? Prescription onlyRoutes oralDoxazosin mesylate, a quinazoline compound sold by Pfizer under the brand names.
number 74191-85-8ATC code C02CA04PubChem 3157DrugBank APRD00474Chemical dataFormula C23H25N5O5Mol. mass 451.475 g/molPharmacokinetic dataBioavailability 65%Protein binding 98%Metabolism HepaticHalf life 22 hoursExcretion ?Therapeutic considerationsPregnancy cat. ?Legal status ? Prescription onlyRoutes oralDoxazosin mesylate, a quinazoline compound sold by Pfizer under the brand names Cardura® and Carduran® , is description of doxazosin 4mg alpha blocker used to treat high blood pressure and description of doxazosin 4mg prostatic hyperplasia.On February description of doxazosin 4mg 2005, the US FDA approved a description of doxazosin 4mg release description of doxazosin 4mg of doxazosin, description of doxazosin 4mg be marketed as Cardura® XL.It is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained release form of doxazosin, to be marketed as Cardura® XL.It is an alpha blocker used to treat high blood pressure and description of doxazosin 4mg prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained release form description of doxazosin 4mg doxazosin, to be marketed as Cardura®.
of doxazosin, to be marketed as Cardura® XL.It is an alpha description of doxazosin 4mg used to treat high blood pressure and benign.
| 
Comments
__________________
I can give the additional information.
__________________
__________________
__________________
To whom is the link to the description of doxazosin 4mg necessary?
It is very necessary!
__________________
I can give the additional information.